News

Published on 17 May 2022 on ETF DAILY NEWS

Analysts’ Updated EPS Estimates for May 17th (ACSO, ALBO, ALT, BEZ, CAML, CCR, CGEM, EGLX, ETSY,...

Article preview image

Analysts’ updated eps estimates for Tuesday, May 17th: accesso Technology Group (LON:ACSO) had its...

Read the rest of the article
LSE.KGF price evolution
NYSE.OPY price evolution
LSE.FRES price evolution
LSE.WTB price evolution
NASDAQ.KALA price evolution
LSE.GSK price evolution
NYSE.GSK price evolution
LSE.TSCO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Madrigal (MDGL) Gains on NASH Treatment's Breakthrough Therapy Tag

Madrigal Pharmaceuticals' MDGL shares were up almost 13% on Apr 18, as its pipeline candidate, re...

Zacks via Yahoo Finance 19 Apr 2023
Biotech Stock Roundup: MDGL, PCVX Up on Study Data, MRNA Provides Updates

The biotech sector has been in focus in the past week with key pipeline and regulatory updates. A...

Zacks via Yahoo Finance 19 Apr 2023
Humanigen (HGEN) Surges on Lenzilumab Study Data for Leukemia

Humanigen HGEN stock was up almost 20% on Apr 14, as it presented the baseline results of its Pre...

Zacks via Yahoo Finance 17 Apr 2023
KALA Up on Fast Track Designation to Lead Ocular Candidate

Kala Pharmaceuticals, Inc. KALA, a clinical-stage biopharmaceutical company’s shares were up 2.52...

Zacks via Yahoo Finance 12 Apr 2023
Apellis (APLS) Stock Up 50% in Three Months: Here's Why?

Apellis’ APLS shares have rallied almost 50% in the past three months against the industry's 5.3%...

Zacks via Yahoo Finance 11 Apr 2023
Emergent's (EBS) Narcan Gets OTC Status for Opioid Overdose

Shares of Emergent Biosciences EBS were up 5.1% on Mar 29, after the FDA granted over-the-counter...

Zacks via Yahoo Finance 30 Mar 2023
Viking (VKTX) Announces Clinical Data for Metabolic Disorders

Shares of Viking Therapeutics VKTX have surged almost 70% on Mar 28, after it announced positive ...

Zacks via Yahoo Finance 29 Mar 2023
Amicus (FOLD) Gets Pompe Disease Treatment Approval in Europe

Amicus FOLD announced that the European Commission approved cipaglucosidase alfa, commercialized ...

Zacks via Yahoo Finance 28 Mar 2023
Zacks Industry Outlook Highlights CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus ...

For Immediate Release Chicago, IL – March 22, 2023 – Today, Zacks Equity Research discusses CRISP...

Zacks via Yahoo Finance 22 Mar 2023
Intellia's (NTLA) HAE Therapy Granted RMAT by the FDA

Shares of Intellia Therapeutics NTLA were up almost 4% on Mar 21, as the company announced that i...

Zacks via Yahoo Finance 22 Mar 2023

Copyright Statfolio @ 2024

Social Accounts